{"altmetric_id":3909186,"counts":{"readers":{"mendeley":5,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["TumorImm_papers"],"posts_count":1}},"selected_quotes":["Tr-1-like CD4+CD25-CD127-\/lowFOXP3- cells are the main source of interleukin 10 in patients with\u2026 #tumorimmuno"],"citation":{"altmetric_jid":"4f6fa4f53cf058f610002df6","authors":["Costa DL","Cardoso TM","Queiroz A","Milanezi CM","Bacellar O","Carvalho EM","Silva JS"],"doi":"10.1093\/infdis\/jiu406","first_seen_on":"2015-04-15T04:03:09+00:00","funders":["niaid"],"issns":["0022-1899"],"journal":"Journal of Infectious Diseases","last_mentioned_on":1429070524,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25139022?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter"],"pmid":"25139022","pubdate":"2014-08-18T23:00:00+00:00","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"},{"name":"Biological Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["communicablediseases"],"title":"Tr-1-Like CD4+CD25-CD127-\/lowFOXP3- Cells Are the Main Source of Interleukin 10 in Patients With Cutaneous Leishmaniasis Due to Leishmania braziliensis.","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/tr1like-cd4cd25cd127lowfoxp3-cells-main-source-interleukin-10-patients-cutaneous-leishmaniasis-due-l-1"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":5000716,"mean":5.9178375524333,"rank":4180933,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":5000716,"percentile":1},"similar_age_3m":{"total_number_of_other_articles":151442,"mean":9.9741470011425,"rank":126853,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":151442,"percentile":1},"this_journal":{"total_number_of_other_articles":3545,"mean":5.9292934537246,"rank":3089,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":3545,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":72,"mean":4.3597183098592,"rank":64,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":72,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Student  > Doctoral Student":1,"Student  > Ph. D. Student":2,"Professor":2},"by_discipline":{"Medicine and Dentistry":1,"Immunology and Microbiology":2,"Agricultural and Biological Sciences":2}}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/TumorImm_papers\/status\/588190526987317248","license":"datasift","citation_ids":[3909186],"posted_on":"2015-04-15T04:02:04+00:00","author":{"name":"TumorImmunoPapers","image":"https:\/\/pbs.twimg.com\/profile_images\/741322452093931520\/rQvFtFTA_normal.jpg","description":"A TwitterBot for Cancer Immunology and Tolerance papers on #PubMed. Curated by @adamsnookphd","id_on_source":"TumorImm_papers","tweeter_id":"2829712275","geo":{"lt":null,"ln":null},"followers":664},"tweet_id":"588190526987317248"}]}}